| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20017201 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20017202 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20039910 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20036459 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44012280 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44027485 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44014592 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44006953 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44032797 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44027486 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PRKCA |
|---|---|
| DrugBank ID | DB06451 |
| Drug Name | Aprinocarsen |
| Target ID | BE0001132 |
| UniProt ID | P17252 |
| Regulation Type | |
| PubMed IDs | 16424642; 15868384 |
| Citations | Lahn M, Sundell K, Kohler G: The role of protein kinase C-alpha in hematologic malignancies. Acta Haematol. 2006;115(1-2):1-8.@@Vansteenkiste J, Canon JL, Riska H, Pirker R, Peterson P, John W, Mali P, Lahn M: Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer. Invest New Drugs. 2005 Jun;23(3):263-9. |
| Groups | Investigational |
| Direct Classification | |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
